Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Treatment of Metastatic Breast Cancer Through Real-Time Disease Monitoring

NCT04906369 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04906369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Treatment of Metastatic Breast Cancer Through Real-Time Disease Monitoring
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Suspended
Start date
November 16, 2020
Completion date
December 30, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, metastatic breast carcinoma, prognostic stage iv breast cancer ajcc v8